CAS 204656-20-2

(4S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-il)propanoyl]amino]propanoyl]amino]-5-id...

Descrizione:

La sostanza chimica con il nome "(4S)-5-[[[5S)-5-[[[2S)-2-[[[2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-5-id" e il numero CAS "204656-20-2" è un peptide complesso con più stereocentri, il che indica che è probabile che mostri chiralità, il che può influenzare la sua attività biologica e le interazioni. Questa sostanza è caratterizzata da una serie di residui di amminoacidi, incluso l'imidazolo, il che suggerisce ruoli potenziali nei sistemi biologici, possibilmente come molecola segnalatrice o nella catalisi enzimatica. La presenza di più gruppi amminici e funzionalità di acido carbossilico indica che potrebbe avere una solubilità significativa in solventi polari e potrebbe partecipare a varie reazioni biochimiche. La sua struttura intricata può anche suggerire proprietà conformazionali specifiche che sono cruciali per la sua funzione in contesti biologici. In generale, questo composto esemplifica la complessità spesso trovata nei peptidi e nelle proteine biologicamente attive.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

InChI: InChI=1/C172H265N43O51/c1-18-20-21-22-23-24-25-26-27-28-29-30-37-53-128(223)193-112(59-64-132(227)228)148(244)180-68-41-40-50-111(154(250)199-116(62-67-135(233)234)155(251)204-120(73-100-44-33-31-34-45-100)160(256)214-140(93(11)19-2)168(264)192-97(15)146(242)201-122(76-103-79-183-108-49-39-38-48-106(103)108)158(254)203-118(72-90(5)6)159(255)212-138(91(7)8)166(262)200-110(52-43-70-182-172(177)178)150(246)184-81-129(224)194-109(51-42-69-181-171(175)176)149(245)187-84-137(237)238)196-144(240)95(13)189-143(239)94(12)191-153(249)115(58-63-127(174)222)195-130(225)82-185-152(248)114(61-66-134(231)232)198-156(252)117(71-89(3)4)202-157(253)119(75-102-54-56-105(221)57-55-102)205-163(259)124(85-216)208-165(261)126(87-218)209-167(263)139(92(9)10)213-162(258)123(78-136(235)236)206-164(260)125(86-217)210-170(266)142(99(17)220)215-161(257)121(74-101-46-35-32-36-47-101)207-169(265)141(98(16)219)211-131(226)83-186-151(247)113(60-65-133(229)230)197-145(241)96(14)190-147(243)107(173)77-104-80-179-88-188-104/h31-36,38-39,44-49,54-57,79-80,88-99,107,109-126,138-142,183,216-221H,18-30,37,40-43,50-53,58-78,81-87,173H2,1-17H3,(H2,174,222)(H,179,188)(H,180,244)(H,184,246)(H,185,248)(H,186,247)(H,187,245)(H,189,239)(H,190,243)(H,191,249)(H,192,264)(H,193,223)(H,194,224)(H,195,225)(H,196,240)(H,197,241)(H,198,252)(H,199,250)(H,200,262)(H,201,242)(H,202,253)(H,203,254)(H,204,251)(H,205,259)(H,206,260)(H,207,265)(H,208,261)(H,209,263)(H,210,266)(H,211,226)(H,212,255)(H,213,258)(H,214,256)(H,215,257)(H,227,228)(H,229,230)(H,231,232)(H,233,234)(H,235,236)(H,237,238)(H4,175,176,181)(H4,177,178,182)/t93-,94-,95-,96-,97-,98+,99+,107-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,125-,126-,138-,139-,140-,141-,142-/m0/s1

Sinonimi:

• Liraglutida [INN-Spanish]
• Liraglutide
• Liraglutidum [INN-Latin]
• Nn 2211
• Nn2211
• Unii-839I73S42A
• Liraglutide [usan:inn]
• Liroglutide
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glp-1-(7-37)-peptide
• Liraglutide /Liraglutide Acetate
• Glycine, L-histidyl-L-alanyl-L-alpha-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-alpha-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-alpha-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-(N-(1-oxohexadecyl)-L-gamma-glutamyl)-L-lysyl-L-alpha-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginyl-
• HAEGTFTSDVSSYLEGQAAK [N-(1-oxohexadecyl)-L-γ-glutaMyl] EFI AWLVRGRG
• (Lys(g-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• Liraglutida
• Liraglutide, (Lys(γ-Glu-palmitoyl)26,Arg34)-GLP-1 (7-37)
• (Lys(γ-Glu-palMitoyl)26,Arg34)-GLP-1 (7-37)
• H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(g-Glu-palMitoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
• Liraglutidum
• Liraglutide Impurity
• Liraglutide injection
• Liraglutide, NN2211
• NNC 90-1170
• N26-(Hexadecanoyl-gamma-glutamyle)-(34-arginine)glucagon-like-peptide-1-(7-37)-peptide
• Victoza

Liraglutide trifluoroacetate salt

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist and used to treat diabetes mellitus type 2 and obesity. The GLP-1 receptor agonists stimulate insulin secretion and inhibit glucagon secretion.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: 98.9%

Peso molecolare: 3751.26

Ref: 01-4041752

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: 99%

Colore e forma: Solid

Peso molecolare: 3751.2020

Ref: IN-DA003RAK

Liraglutide-d8 Tritrifluoroacetate

CAS: 204656-20-2

Formula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·3C₂HF₃O₂

Colore e forma: White To Off-White Solid

Peso molecolare: 3759.31 3*114.02

Ref: 4Z-PL-105002

Liraglutide-d8 Tetratrifluoroacetate

CAS: 204656-20-2

Formula: C₁₇₂H₂₅₇D₈N₄₃O₅₁·4C₂HF₃O₂

Peso molecolare: 3759.31 4*114.02

Ref: 4Z-PL-105047

Liraglutide

CAS: 204656-20-2

Liraglutide

Peso molecolare: 3751g/mol

Ref: 54-BI9895

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Colore e forma: White To Off-White Solid

Peso molecolare: 3751.26

Ref: 4Z-PL-105001

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: 95%~99%

Colore e forma: White to Off-white Powder

Peso molecolare: 3751. 20

Ref: BP-BPPG046

Liraglutide

CAS: 204656-20-2

Liraglutide (Liraglutida) is a synthetic analog of GLP-1, an agonist of the GLP-1 receptor. Liraglutide is an antidiabetic agent. Cost effective and quality assured.

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: 97.65% - 99.04%

Colore e forma: Solid

Peso molecolare: 3751.25

Ref: TM-T6876

Liraglutide

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: ≥ 98.0%

Colore e forma: White to off-white powder

Peso molecolare: 3751.2

Ref: 7W-GX3695

Liraglutide

Prodotto controllato

CAS: 204656-20-2

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Colore e forma: Off-White

Peso molecolare: 3751.2

Ref: TR-L468860

Liraglutide sodium

CAS: 204656-20-2

Please enquire for more information about Liraglutide sodium  including the price, delivery time and more detailed product information at the technical inquiry form on this page

Formula: C₁₇₂H₂₆₅N₄₃O₅₁•(Na)x

Ref: 3D-BL184581

Liraglutide

CAS: 204656-20-2

Liraglutide is a glucagon-like peptide-1 analog that has been shown to be an effective treatment for obesity. Liraglutide targets the adipose tissue and reduces the amount of glucose in the blood by increasing insulin sensitivity, lowering food intake, and reducing appetite. In addition, Liraglutide has been shown to suppress postprandial hyperglycemia and lower plasma glucose levels in patients with type 2 diabetes mellitus. Liraglutide also inhibits neuronal death induced by apoptotic stimuli, which may have potential use as a model system for neurodegenerative diseases such as Parkinson's disease. Liraglutide has also been shown to be an effective therapy for infectious diseases including Crohn's disease and ulcerative colitis. This drug has shown some effectiveness against atherosclerosis in animal models by inducing apoptosis in macrophages that are associated with lesions. It has also been found to have beneficial

Formula: C₁₇H₂₆₅N₄₃O₅₁

Purezza: Min. 95%

Peso molecolare: 3,751.29 g/mol

Ref: 3D-PGL-3781-PI

Liraglutide

CAS: 204656-20-2

Glucagon-like peptide 1 (GLP-1) receptor agonist; hypoglycemic agent

Formula: C₁₇₂H₂₆₅N₄₃O₅₁

Purezza: Min. 95 Area-%

Colore e forma: White Powder

Peso molecolare: 3,751.2 g/mol

Ref: 3D-FL109949